7.4 Enteric Infections: Cholera, Typhoid Fever & Diarrhoea Outbreak Response

7.4 Enteric Infections: Cholera, Typhoid Fever & Diarrhoea Outbreak Response

Quick Answer: Enteric infections represent acute clinical and public health challenges across Ghana, with cholera and typhoid fever driving significant outbreak morbidity. Cholera, caused by Vibrio cholerae, triggers massive watery "rice-water" diarrhea through cholera enterotoxin-mediated hypersecretion, resulting in lethal hypovolemic shock within hours. Clinical management is guided by the World Health Organization dehydration classification: Plan A (home fluids/ORS for no dehydration), Plan B (oral rehydration at $75\text{ mL/kg}$ over 4 hours for some dehydration), and Plan C (rapid intravenous Ringer's Lactate at $100\text{ mL/kg}$ for severe dehydration: $30\text{ mL/kg}$ in 30 minutes, then $70\text{ mL/kg}$ over 2.5 hours). Typhoid fever (Salmonella enterica serotype Typhi) presents with step-ladder fever, relative bradycardia (Faget's sign), and risks life-threatening terminal ileal perforation during week 3. Community outbreak response demands Cholera Treatment Centre (CTC) zoning and rigorous chlorine disinfection (0.05% for hands; 0.5% for vomitus/excreta).

---

Cholera: Microbiology, Pathophysiology, and Clinical Picture

Cholera is an acute bacterial diarrheal disease caused by toxigenic strains of Vibrio cholerae belonging to the O1 (biotypes Classical and El Tor, serotypes Ogawa, Inaba, and Hikojima) and O139 serogroups. V. cholerae is a comma-shaped, highly motile, Gram-negative bacterium propelled by a single polar flagellum. Transmission occurs via the fecal-oral route through ingestion of water or food contaminated directly or indirectly with human feces or vomitus.

                  CHOLERA ENTEROTOXIN PATHOPHYSIOLOGY
                                   |
        Ingestion of V. cholerae in Contaminated Water / Food
                                   |
        Passage through Gastric Acid Barrier (High infectious dose)
                                   |
        Colonization of Small Intestinal Mucosa via Toxin-Coregulated Pili
                                   |
        Secretion of Cholera Toxin (AB5 Enterotoxin)
                                   |
        B Subunit Pentamer binds to GM1 Ganglioside Receptors on Enterocytes
                                   |
        A1 Catalytic Subunit Translocates into Cytoplasm
                                   |
        ADP-Ribosylation of Gs Alpha Regulatory Protein
                                   |
        Permanent, Irreversible Activation of Adenylate Cyclase
                                   |
        Massive Intracellular Surge in Cyclic AMP (cAMP)
                                   |
        +--------------------------+--------------------------+
        |                                                     |
Phosphorylation of CFTR Channels               Inhibition of Electroneutral NaCl Absorption
Active Secretion of Cl-, Na+, K+, HCO3-                 across Intestinal Brush Border
        |                                                     |
        +--------------------------+--------------------------+
                                   |
        Massive Osmotic Transudation of Free Water into Bowel Lumen
        (Exceeds colon's absorptive capacity -> Profuse Rice-Water Diarrhea)

Clinical Manifestations

Following an incubation period ranging from a few hours to 5 days (typically 24 to 48 hours), symptoms manifest abruptly:

• Rice-Water Diarrhea: Sudden onset of painless, voluminous, non-offensive watery diarrhea resembling water in which rice has been boiled (translucent, greyish, containing suspended flakes of mucus and epithelial cells). Stool volume can exceed 500 to 1,000 mL/hour, producing up to 20 liters of fluid loss daily.
• Effortless Vomiting: Early, copious vomiting that occurs effortlessly without preceding nausea or retching.
• Severe Muscle Cramps: Painful cramping occurring predominantly in the calves, thighs, and abdomen, triggered by rapid hypokalemic, hyponatremic, and hypocalcemic fluid shifts.
• Rapid Hypovolemic Shock: Lethal circulatory collapse can develop within 2 to 6 hours of onset: sunken eyes, hollow cheeks, lost skin turgor, hoarse whispery voice (vox cholerica), thready or absent radial pulses, cold clammy extremities, cyanosis, and acute anuria.

---

WHO Dehydration Assessment Framework

Evaluating the degree of volume depletion is the critical first nursing action in any patient presenting with acute watery diarrhea. The WHO standard classification dictates the immediate fluid management pathway:

[!IMPORTANT] Diagnostic Rule: To classify a patient into "Some Dehydration" or "Severe Dehydration", the patient must exhibit at least two of the signs in that column, including at least one key sign (bolded: mental status or drinking ability).

---

Rehydration Resuscitation Protocols: Plans A, B, and C

Fluid replacement must immediately match prior deficit and ongoing losses.

Treatment Plan A: Home Therapy & Prevention of Dehydration

Administered to patients with no signs of dehydration to prevent volume deficit. Counsel the caregiver on the Four Rules of Home Treatment:

1. Give extra fluids: Low-osmolarity ORS, rice water, vegetable soup, coconut water, clean water. Administer after every loose stool:
   • Children $< 2\text{ years}$: $50\text{--}100\text{ mL}$
   • Children $2\text{--}9\text{ years}$: $100\text{--}200\text{ mL}$
   • Older children and adults: As much as they want (typically $200\text{--}400\text{ mL}$)
2. Give Zinc supplements: For 10 to 14 days.
3. Continue frequent feeding: Breastfeeding on demand; nutritious energy-dense meals.
4. Danger signs education: Return immediately if vomiting increases, high fever develops, stool contains blood, or child drinks poorly.

Treatment Plan B: Oral Rehydration for Some Dehydration

Administered in a health facility observation corner over a 4-hour period:

• Prescribed ORS Volume: $75\text{ mL/kg}$ of low-osmolarity ORS given over 4 hours (e.g., a 10 kg child receives $750\text{ mL}$). If weight is unknown, use age-based charts.
• Administration Technique: Provide frequent small sips using a cup and spoon. If the child vomits, wait 10 minutes, then resume administration more slowly (1 teaspoon every 2 minutes).
• Reassessment at 4 Hours: Re-evaluate hydration status against the WHO table:
  • If no dehydration signs remain $\rightarrow$ switch to Plan A.
  • If some dehydration signs persist $\rightarrow$ repeat Plan B for another 4 hours.
  • If severe dehydration develops $\rightarrow$ immediately transition to Plan C.

Treatment Plan C: Emergency Intravenous Resuscitation for Severe Dehydration

Severe dehydration is a life-threatening emergency requiring rapid vascular volume restoration.

• Fluid of Choice: Ringer's Lactate is the first-line intravenous fluid. It supplies appropriate sodium concentrations, potassium to replace stool losses, and lactate which is metabolized by the liver into bicarbonate to reverse metabolic acidosis. (If Ringer's Lactate is unavailable, 0.9% Normal Saline is second-line; pure dextrose solutions are lethal and contraindicated for resuscitation).
• Total Prescribed Volume: $100\text{ mL/kg}$ intravenous Ringer's Lactate administered in two distinct phases:

• Resuscitation Monitoring: Reassess radial pulse volume, capillary refill, and mental status every 15 to 30 minutes. If the pulse remains undetectable after the initial 30 mL/kg, repeat the 30 mL/kg bolus immediately over 30 minutes.
• Transition to Oral ORS: As soon as the patient is conscious and can swallow safely (usually after the initial 30 mL/kg bolus), start providing oral ORS at approximately $5\text{ mL/kg/hour}$ alongside the running IV infusion to replace potassium and bicarbonate losses.

---

Oral Rehydration Salts (ORS) Composition and Zinc Therapy

WHO low-osmolarity ORS utilizes the physiological principle that active sodium-glucose co-transport (SGLT-1) across enterocyte brush-border membranes remains functional despite cholera enterotoxin activity. Equimolar luminal glucose and sodium bind the transporter, driving active intracellular transport, which creates an osmotic gradient that pulls water passively from the lumen into the vascular compartment.

Pediatric Zinc Supplementation Protocol

Zinc is a critical micronutrient required for intestinal epithelial cell renewal, protein synthesis, and mucosal immune response. Zinc supplementation administered daily for 10 to 14 days reduces diarrhea duration, diminishes stool volume by up to 30%, and prevents recurrent diarrheal episodes over the subsequent 2 to 3 months:

• Infants under 6 months: 10 mg elemental zinc daily for 10 to 14 days (dissolved in clean water or breastmilk).
• Children 6 months to 5 years: 20 mg elemental zinc daily for 10 to 14 days.

---

Antibiotic Therapy in Cholera

Antibiotics are a secondary adjunct indicated solely for patients with severe dehydration or high stool output. Effective antimicrobials eliminate vibrios from stool within 48 hours, reduce diarrhea volume by 50%, and shorten duration of illness:

• First-Line for Adults: Doxycycline 300 mg orally as a single dose.
• Alternative for Adults & Preferred in Pregnancy/Children: Azithromycin 1 g orally as a single dose ($20\text{ mg/kg}$ in children).
• Second-Line: Ciprofloxacin 1 g single dose or 500 mg twice daily for 3 days.

---

Typhoid Fever (Enteric Fever): Pathogenesis and Clinical Trajectory

Typhoid fever is a systemic bacteremic infection caused by Salmonella enterica serotype Typhi (and Salmonella enterica serotypes Paratyphi A, B, and C). Ingested organisms traverse the stomach, invade the terminal ileum via microfold (M) cells overlying Peyer's patches, and are phagocytosed by mononuclear macrophages. Instead of being destroyed, S. Typhi resists oxidative killing, survives within the macrophage phagosome, and disseminates via mesenteric lymphatics to the reticuloendothelial organs (liver, spleen, bone marrow, and gallbladder) during an asymptomatic incubation period of 7 to 14 days.

                    CLINICAL TIMELINE OF UNTREATED TYPHOID FEVER
                                         |
    +------------------------------------+------------------------------------+
    |                                                                         |
[WEEK 1: BACTEREMIC ONSET]                               [WEEK 2: RETICULOENDOTHELIAL LOCALIZATION]
- Insidious "step-ladder" rising fever                   - Sustained high plateau fever (39.5 - 40 C)
- Dull frontal headache & malaise                        - "Typhoid facies" (apathetic, prostrate expression)
- Faget's Sign: Relative bradycardia                     - "Rose spots" on trunk (blanching macules)
- Dry cough, abdominal discomfort                        - Tender right iliac fossa, splenomegaly
- Diagnostic yield: BLOOD CULTURE (80%)                  - "Pea-soup" diarrhea or severe constipation
                                                         - Diagnostic yield: WIDAL / BLOOD CULTURE
                                         |
    +------------------------------------+------------------------------------+
    |                                                                         |
[WEEK 3: INTESTINAL COMPLICATIONS]                       [WEEK 4: DEFERVESCENCE OR CHRONICITY]
- Profound toxemia / "Typhoid state"                     - Fever subsides gradually by lysis
  (Muttering delirium, coma-vigil)                       - Resolution in uncomplicated cases
- Hypertrophied Peyer's patches ulcerate                 - Chronic Gallbladder Carriage (1-4%):
- Massive Lower GI Hemorrhage (10-15%)                     Persistent shedding in stool for > 1 year;
- ACUTE ILEAL PERFORATION (2-5%):                          reservoir for community transmission
  (Board-like rigidity, free air under diaphragm)        - Diagnostic yield: STOOL CULTURE

Clinical Trajectory by Week

1. Week 1 (Bacteremic Onset): Insidious onset with a classic "step-ladder" remittent fever that climbs daily by 0.5 to 1.0 C, peaking in the evening. Frontal headache, dry cough, and malaise. A classic hemodynamic feature is relative bradycardia (Faget's sign)—the pulse rate is disproportionately slow for the prevailing body temperature (e.g., a pulse of 75 bpm at a core temperature of 39.5 C).
2. Week 2 (Organ Localization): Sustained plateau fever (39.5 to 40.0 C). Patient appears dull, drowsy, and apathetic. Physical exam reveals abdominal distension, tender right iliac fossa, and splenomegaly. Approximately 10-20% of fair-skinned patients display "rose spots"—faint, salmon-pink, blanching maculopapular lesions on the abdomen and chest. Stool transitions from constipation to foul-smelling, greenish "pea-soup" diarrhea.
3. Week 3 (Toxemia & Intestinal Disasters): The patient enters the "typhoid state"—marked by profound toxemia, muttering delirium, picking at bedclothes (carphology), and coma-vigil. Necrosis and sloughing of Peyer's patches in the terminal ileum precipitate lethal complications:
   • Intestinal Hemorrhage (10-15%): Erosion into mucosal blood vessels causes sudden hypovolemia, temperature drop, and massive melena.
   • Acute Ileal Perforation (2-5%): Full-thickness necrotic erosion through the antimesenteric border of the terminal ileum. Manifests as sudden severe abdominal pain, board-like abdominal rigidity, rebound tenderness, absent bowel sounds, and free subdiaphragmatic air on an erect abdominal radiograph. Requires immediate laparotomy and surgical repair.
4. Week 4 (Resolution or Carriage): If the patient survives, fever resolves by slow lysis over several days. Approximately 1% to 4% of individuals become chronic carriers, harboring bacilli in the gallbladder for $> 1\text{ year}$ and shedding them intermittently in stool.

Diagnostic Workup & Treatment

• Blood Culture: Diagnostic gold standard during Week 1 (sensitivity 70-85%).
• Bone Marrow Culture: Most sensitive diagnostic modality (> 90%), remaining positive even after antibiotic administration.
• Stool Culture: Yields positive results in Week 3 and is mandatory for evaluating chronic carriage.
• Widal Agglutination Test Limitations: Widely overutilized in Ghana; measures agglutinating antibodies against S. Typhi O (somatic) and H (flagellar) antigens. It has low specificity and poor positive predictive value; cross-reactions with malaria, dengue, enterobacteriaceae, and prior vaccination produce frequent false-positive results. A single isolated titer is non-diagnostic; confirmation requires demonstrating a four-fold rise in antibody titers in paired acute and convalescent sera taken 10 to 14 days apart.
• Antimicrobial Therapy: First-line for uncomplicated typhoid: Ciprofloxacin 500 mg orally twice daily for 7 to 10 days, or Azithromycin 1 g orally once daily for 5 to 7 days. For severe or hospitalized enteric fever: IV Ceftriaxone 2 g once daily for 10 to 14 days.

---

Outbreak Management: Cholera Treatment Centre (CTC) & WASH Interventions

When a community cholera outbreak is declared, healthcare facilities establish dedicated Cholera Treatment Centres (CTCs) or Cholera Treatment Units (CTUs) to isolate cases and prevent nosocomial cross-infection.

                   CHOLERA TREATMENT CENTRE (CTC) LAYOUT
                                     |
  [ENTRANCE] ---> [TRIAGE & SCREENING] (Handwashing 0.05% Chlorine + Footbath)
                         |
         +---------------+---------------+
         |                               |
  [PLAN B: OBSERVATION AREA]     [PLAN C: INPATIENT ADMISSION]
  - Oral ORS administration      - Cholera beds with collection buckets
  - Low-risk monitoring          - Rapid IV Ringer's Lactate access
  - Ambulatory toilets (0.5%)    - Strict barrier nursing
         |                               |
         +---------------+---------------+
                         |
  [CLEAN ZONE] (Staff quarters, pharmacy, food preparation, clean stores)
                         |
  [EXIT] (Footbath 0.05% Chlorine, Waste zone with Morgue & Pit latrines 0.5%)

CTC Operational Architecture

• Zoning and Access Control: Demarcate clean areas (staff rest, pharmacy, clean supply store) strictly separated from contaminated patient care zones (triage, Plan B observation, Plan C inpatient ward, morgue, and waste management area).
• Cholera Beds (Cholera Cots): Specially constructed wooden or metal cots covered with waterproof, smooth plastic sheeting. A circular opening (20 cm diameter) in the center of the bed allows stool to pass directly into a calibrated plastic bucket placed underneath containing 0.5% chlorine solution. This allows continuous, accurate measurement of fluid loss without soiling linens.

Chlorine Dilution and Disinfection Standards

Chlorine is the disinfectant of choice. Two standardized concentrations must be maintained at all times:

1. 0.05% Chlorine Solution (500 ppm active chlorine):
   • Usage: Handwashing stations, footbaths at entrance/exit of each zone, bathing ambulatory patients, washing patients' dishes and eating utensils.
   • Preparation from High-Test Hypochlorite (HTH 70%): Dissolve 1 tablespoon (15 g) of HTH granules in 20 liters of clean water.
2. 0.5% Chlorine Solution (5,000 ppm active chlorine):
   • Usage: Disinfecting cholera beds, mattresses, floors, toilets, latrines, ambulances, spills of vomitus/feces, and decontamination of cadavers prior to burial.
   • Preparation from HTH (70%): Dissolve 10 tablespoons (150 g) of HTH granules in 20 liters of clean water.

WASH & Community Interventions

• Safe Water Provision: Distribution of household water disinfection tablets (sodium dichloroisocyanurate / Aquatabs) and promotion of boiling drinking water vigorously for at least 1 minute.
• Sanitation: Construction of emergency deep-trench latrines situated at least 30 meters away from all water sources and 1.5 meters above the water table.
• Safe Burial Practices: Dead bodies of cholera victims are highly infectious; corpses must be washed with 0.5% chlorine solution, wrapped in leak-proof body bags, and buried promptly without communal meals or open touching.